Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Chinese adults期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Chinese adults

Authors:	Pan Xiaolin Li Yuqing Qiu Yuping Tang Qiyun Qian Bingbing Yao Linhua Shi Ruihua Zhang Guoxin

Affiliation:	Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Abstract:

Keywords:
本文献已被 PubMed 等数据库收录！